| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Not specified | |||
| NCT06693024 | Adjuvant Therapy With Neratinib in HER2 Positive Early Breast Cancer | HER2-positive Breast Cancer | Recruiting |
| NCT06693037 | Adjuvant Therapy Choice for Non-pCR HER2 Positive Early Breast Cancer After Neoadjuvant… | HER2-positive Breast Cancer | Recruiting |
| NCT06700369 | De-escalation of Neoadjuvant Chemotherapy Regimens With Targeted Therapy Among HER2… | HER2-positive Breast Cancer | Recruiting |
| NCT06700382 | Different Methods of Capecitabine in Patients With Non-PCR After Neoadjuvant Therapy for… | Triple Negative Breast Cancer | Recruiting |
| NCT06711055 | Taxane Combined Targeted Therapy for Low-risk HER2 Positive and Lymph Node Negative… | HER2-positive Breast Cancer | Recruiting |
| NCT06711068 | Adjuvant Therapy for Intermediate Risk HER2 Positive, Lymph Node Negative Early Breast… | HER2-positive Breast Cancer | Recruiting |
| NCT06722599 | Four Cycles Taxane With Trastuzumab and Pertuzumab Neoadjuvant Therapy Among Low Risk… | HER2-positive Breast Cancer | Recruiting |
| NCT06722612 | Chemotherapy Combined With Targeted Therapy for High-risk HER2 Positive and Lymph Node… | HER2-positive Breast Cancer | Recruiting |